Added to YB: 2022-01-11
Pitch date: 2022-01-11
CRVS [bullish]
Corvus Pharmaceuticals, Inc.
+284.86%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.
Market Cap
$655.0M
Pitch Price
$2.18
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.23
P/E
-15.70
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
CORVUS PHARMACEUTICALS INC CRVS
A summary for this pitch has not been created yet.
Read full article (0 min)